AVXL Operating Cash Flow (Statement)
Anavex Life Sciences Corp · Operating Cash Flow (Statement)
AVXL Operating Cash Flow (Statement)
Latest reported-$13.54Mperiod ending
AVXL Quarterly Cash from Operations (-$1.09K → -$13.54M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
AVXL operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -13,536,000 | |
| -4,440,000 | |
| -7,151,000 | |
| -8,604,000 | |
| -12,464,000 | |
| -5,856,000 | |
| -12,120,000 | |
| -6,658,000 | |
| -5,180,000 | |
| -11,656,000 | |
| -7,318,000 | |
| -5,849,629 | |
| -7,653,000 | |
| -8,489,000 | |
| -5,794,000 | |
| -4,043,935 | |
| -7,053,490 | |
| -9,639,484 | |
| -3,500,955 | |
| -7,674,508 | |
| -7,520,943 | |
| -7,316,845 | |
| -7,871,378 | |
| -6,254,772 | |
| -4,044,223 | |
| -5,262,892 | |
| -5,725,159 | |
| -2,534,306 | |
| -7,501,184 | |
| -4,331,458 | |
| -4,160,169 | |
| -4,053,172 | |
| -2,088,134 | |
| -2,820,967 | |
| -3,620,133 | |
| -2,191,883 | |
| -2,973,980 | |
| -697,742 | |
| -3,153,626 | |
| -1,863,267 | |
| -2,223,807 | |
| -1,902,557 | |
| -3,247,192 | |
| -1,433,359 | |
| -1,430,296 | |
| -670,281 | |
| -693,070 | |
| -916,855 | |
| -960,005 | |
| -347,529 | |
| -434,990 | |
| -484,508 | |
| -32,190 | |
| -129,302 | |
| -131,573 | |
| -251,933 | |
| -238,702 | |
| -114,182 | |
| -1,088,123 | |
| -922,589 | |
| -1,205,987 | |
| -588,942 | |
| -1,083,961 | |
| -1,663,586 | |
| -1,099,048 | |
| -1,050,994 | |
| -779,960 | |
| -971,342 | |
| -1,181,386 | |
| -373,603 | |
| -268,324 | |
| -764,452 | |
| -597,558 | |
| -435,600 | |
| -676,443 | |
| -60,093 | |
| -202,904 | |
| -54,494 | |
| -7,759 | |
| -41,271 | |
| 27,137 | |
| -17,208 | |
| -1,086 | |
| -20,541 | |
| 0 | |
| -39,445 | |
| -1,086 |